France takes stake in Sanofi
Yen on MSN22h
Sanofi pursues sale of France's leading painkiller to US investment fund after controversyFrench pharmaceutical company Sanofi confirmed on Monday its plans to sell a controlling stake in its consumer health ...
Sanofi is now in “exclusive negotiations” with U.S. private equity firm Clayton, Dubilier & Rice (CD&R) to sell a 50% ...
Sanofi, which is joining a growing number of drugmakers shedding consumer related businesses, said Opella had been valued at ...
Under the trilateral deal signed by Sanofi, CD&R and the government, Opella will have to pay a €40 million penalty if it ...
1d
The proposed sale turned into a real political issue because Opella's products include Doliprane, the best-selling medicine ...
Sanofi and CD&R announce a plan to join forces to fuel Opella’s ambitions as a French-headquartered, global consumer healthcare champion. Sanofi and CD&R have entered exclusive negotiations for the ...
The sale of a French drugmaker to an American group is likely to now go ahead after French Economy Minister Antoine Armand ...
GlobalData on MSN14h
Sanofi’s $17bn sale of Opella to US investors advances following government dealA stake by France-owned Bpifrance and promise of local job retention have allayed political backlash over the sale of ...
French drugmaker Sanofi's Monday confirmation that it plans to sell a controlling stake in its over-the-counter unit to a US ...
Sanofi (SNYNF) announced it has entered into exclusive negotiations to sell a 50 percent controlling stake in its consumer healthcare ...
French drugmaker Sanofi's confirmation that it will sell a controlling stake in its consumer health unit Opella to a US ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback